Case-Based Roundtable Meetings Spotlight: December 1, 2022

Phillips Evaluates Second-Line Therapy Options for R/R DLBCL

December 14, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Tycel Phillips, MD, discussed available therapies for a patient with relapsed/refractory diffuse large B-cell lymphoma including CAR T-cell therapy and combination systemic therapies.

Levy Discusses Treatment Options for ALK-Rearranged NSCLC

December 12, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Benjamin Levy, MD, discussed the current targeted treatment options that target lung cancers that are positive for ALK rearrangements.